• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For August 15, 2022

    8/15/22 5:30:10 AM ET
    $ABOS
    $ADES
    $ALBO
    $AMPS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Major Chemicals
    Industrials
    Get the next $ABOS alert in real time by email

     

    Companies Reporting Before The Bell

    • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter.

    • GreenPower Motor Co (NASDAQ:GP) is estimated to report quarterly loss at $0.15 per share on revenue of $5.59 million.

    • Mondee Hldgs (NASDAQ:MOND) is likely to report quarterly loss at $0.04 per share on revenue of $38.94 million.

    • Reshape Lifesciences (NASDAQ:RSLS) is expected to report quarterly loss at $0.35 per share on revenue of $3.41 million.

    • Alaunos Therapeutics (NASDAQ:TCRT) is expected to report earnings for its second quarter.

    • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $0.19 per share on revenue of $5.25 million.

    • IM Cannabis (NASDAQ:IMCC) is estimated to report quarterly earnings at $0.01 per share on revenue of $20.60 million.

    • Wejo Gr (NASDAQ:WEJO) is expected to report earnings for its second quarter.

    • Impel Pharmaceuticals (NASDAQ:IMPL) is likely to report quarterly loss at $1.05 per share on revenue of $3.83 million.

    • TherapeuticsMD (NASDAQ:TXMD) is expected to report quarterly loss at $3.04 per share on revenue of $23.20 million.

    • SPDR Select Sector Fund - Consumer Discretionary (NYSE:XLY) is likely to report quarterly loss at $0.01 per share on revenue of $25.70 million.

    • SCYNEXIS (NASDAQ:SCYX) is expected to report earnings for its second quarter.

    • Medicenna Therapeutics (NASDAQ:MDNA) is likely to report earnings for its first quarter.

    • Roivant Sciences (NASDAQ:ROIV) is projected to report earnings for its first quarter.

    • Fathom Digital Mfg (NYSE:FATH) is expected to report quarterly loss at $0.01 per share on revenue of $43.46 million.

    • Gamida Cell (NASDAQ:GMDA) is likely to report earnings for its second quarter.

    • Viridian Therapeutics (NASDAQ:VRDN) is projected to report quarterly loss at $0.90 per share on revenue of $230 thousand.

    • Protalix BioTherapeutics (AMEX:PLX) is projected to report earnings for its second quarter.

    • ATAI Life Sciences (NASDAQ:ATAI) is expected to report earnings for its second quarter.

    • Stran & Co (NASDAQ:STRN) is projected to report earnings for its second quarter.

    • Li Auto (NASDAQ:LI) is projected to report quarterly loss at $0.06 per share on revenue of $1.12 billion.

    • Celsion (NASDAQ:CLSN) is estimated to report quarterly loss at $1.12 per share on revenue of $80 thousand.

    • CBAK Energy Tech (NASDAQ:CBAT) is estimated to report earnings for its second quarter.

    • Rockwell Medical (NASDAQ:RMTI) is projected to report earnings for its second quarter.

    • Stratus Properties (NASDAQ:STRS) is projected to report earnings for its second quarter.

    • Harbor Custom Dev (NASDAQ:HCDI) is expected to report quarterly earnings at $0.01 per share on revenue of $34.05 million.

    • Inuvo (AMEX:INUV) is projected to report quarterly loss at $0.01 per share on revenue of $20.05 million.

    • Stryve Foods (NASDAQ:SNAX) is expected to report quarterly loss at $0.33 per share on revenue of $13.45 million.

    • AEye (NASDAQ:LIDR) is likely to report quarterly loss at $0.15 per share on revenue of $830 thousand.

    • Sterling Bancorp (NASDAQ:SBT) is projected to report earnings for its second quarter.

    • Altus Power (NYSE:AMPS) is estimated to report earnings for its second quarter.

    • Weber (NYSE:WEBR) is estimated to report earnings for its third quarter.

    • WiSA Technologies (NASDAQ:WISA) is estimated to report earnings for its second quarter.

    • Gracell Biotechnologies (NASDAQ:GRCL) is estimated to report earnings for its second quarter.

    • Brainstorm Cell (NASDAQ:BCLI) is projected to report earnings for its second quarter.

    • Clear Secure (NYSE:YOU) is expected to report earnings for its second quarter.

    • Embecta (NASDAQ:EMBC) is expected to report quarterly earnings at $0.87 per share on revenue of $276.86 million.

    • Thoughtworks Holding (NASDAQ:TWKS) is likely to report quarterly earnings at $0.11 per share on revenue of $328.34 million.

    • Niu Technologies (NASDAQ:NIU) is projected to report earnings for its second quarter.

    • DouYu Intl Hldgs (NASDAQ:DOYU) is expected to report quarterly loss at $0.04 per share on revenue of $263.99 million.

    • UpHealth (NYSE:UPH) is projected to report quarterly loss at $0.08 per share on revenue of $45.00 million.

    • Gelesis Holdings (NYSE:GLS) is likely to report earnings for its second quarter.

    • Kalera (NASDAQ:KAL) is projected to report earnings for its second quarter.

    • Bitfarms (NASDAQ:BITF) is projected to report earnings for its second quarter.

    Companies Reporting After The Bell

    • Acumen Pharmaceuticals (NASDAQ:ABOS) is estimated to report earnings for its second quarter.

    • Vivos Therapeutics (NASDAQ:VVOS) is projected to report earnings for its second quarter.

    • GSE Systems (NASDAQ:GVP) is estimated to report earnings for its second quarter.

    • Navitas Semiconductor (NASDAQ:NVTS) is likely to report quarterly loss at $0.09 per share on revenue of $8.42 million.

    • Neptune Wellness Solns (NASDAQ:NEPT) is estimated to report quarterly loss at $2.45 per share on revenue of $18.00 million.

    • Tivic Health Systems (NASDAQ:TIVC) is projected to report earnings for its second quarter.

    • mCloud Technologies (NASDAQ:MCLD) is estimated to report earnings for its second quarter.

    • Biotricity (NASDAQ:BTCY) is estimated to report quarterly loss at $0.11 per share on revenue of $2.19 million.

    • Assure Hldgs (NASDAQ:IONM) is expected to report quarterly loss at $0.23 per share on revenue of $6.08 million.

    • Dolphin Entertainment (NASDAQ:DLPN) is projected to report quarterly earnings at $0.08 per share on revenue of $10.30 million.

    • iSun (NASDAQ:ISUN) is expected to report earnings for its second quarter.

    • Phoenix New Media (NYSE:FENG) is expected to report earnings for its second quarter.

    • Icecure Medical (NASDAQ:ICCM) is estimated to report earnings for its first quarter.

    • Stronghold Digital Mining (NASDAQ:SDIG) is projected to report earnings for its second quarter.

    • CVD Equipment (NASDAQ:CVV) is projected to report earnings for its second quarter.

    • Amtech Systems (NASDAQ:ASYS) is estimated to report quarterly loss at $0.28 per share on revenue of $14.72 million.

    • Quipt Home Medical (NASDAQ:QIPT) is expected to report earnings for its third quarter.

    • Blend Labs (NYSE:BLND) is projected to report quarterly loss at $0.19 per share on revenue of $58.32 million.

    • Verb Tech (NASDAQ:VERB) is likely to report quarterly loss at $0.06 per share on revenue of $2.93 million.

    • Midwest Holding (NASDAQ:MDWT) is projected to report quarterly loss at $0.21 per share on revenue of $10.40 million.

    • Greenidge Generation Hldg (NASDAQ:GREE) is expected to report quarterly loss at $0.12 per share on revenue of $46.10 million.

    • Enthusiast Gaming (NASDAQ:EGLX) is estimated to report quarterly loss at $0.09 per share on revenue of $50.26 million.

    • Kubient (NASDAQ:KBNT) is estimated to report quarterly loss at $0.22 per share on revenue of $1.20 million.

    • INVO Bioscience (NASDAQ:INVO) is likely to report quarterly loss at $0.24 per share on revenue of $330 thousand.

    • Biora Therapeutics (NASDAQ:BIOR) is estimated to report earnings for its second quarter.

    • Creative Realities (NASDAQ:CREX) is estimated to report earnings for its second quarter.

    • Arcimoto (NASDAQ:FUV) is estimated to report quarterly loss at $0.30 per share on revenue of $2.25 million.

    • F45 Training Holdings (NYSE:FXLV) is expected to report quarterly earnings at $0.14 per share on revenue of $50.17 million.

    • HyreCar (NASDAQ:HYRE) is expected to report quarterly loss at $0.25 per share on revenue of $10.46 million.

    • Blackboxstocks (NASDAQ:BLBX) is likely to report quarterly loss at $0.08 per share on revenue of $1.45 million.

    • Ginkgo Bioworks Holdings (NYSE:DNA) is likely to report quarterly loss at $0.04 per share on revenue of $77.63 million.

    • Ferroglobe (NASDAQ:GSM) is estimated to report quarterly earnings at $0.84 per share on revenue of $738.10 million.

    • SpringBig Holdings (NASDAQ:SBIG) is expected to report quarterly loss at $0.21 per share on revenue of $7.20 million.

    • Recruiter.Com Group (NASDAQ:RCRT) is likely to report quarterly loss at $0.25 per share on revenue of $7.20 million.

    • Sanara MedTech (NASDAQ:SMTI) is estimated to report earnings for its second quarter.

    • Sunlight Finl Hldgs (NYSE:SUNL) is expected to report quarterly earnings at $0.05 per share on revenue of $34.52 million.

    • Field Trip Health (NASDAQ:FTRP) is estimated to report quarterly loss at $0.16 per share on revenue of $1.79 million.

    • Fluence Energy (NASDAQ:FLNC) is likely to report quarterly loss at $0.34 per share on revenue of $227.93 million.

    • FiscalNote Holdings (NYSE:NOTE) is projected to report quarterly loss at $0.44 per share on revenue of $29.14 million.

    • Cemtrex (NASDAQ:CETX) is expected to report earnings for its third quarter.

    • Calithera Biosciences (NASDAQ:CALA) is expected to report earnings for its second quarter.

    • Immersion (NASDAQ:IMMR) is likely to report earnings for its second quarter.

    • American Res (NASDAQ:AREC) is estimated to report earnings for its second quarter.

    • Grupo Televisa (NYSE:TV) is projected to report quarterly loss at $0.03 per share on revenue of $68.84 million.

    • Charah Solns (NYSE:CHRA) is likely to report quarterly loss at $0.21 per share on revenue of $79.48 million.

    • TMC Metals (NASDAQ:TMC) is estimated to report earnings for its third quarter.

    • Nu Holdings (NYSE:NU) is expected to report earnings for its second quarter.

    • Advanced Emissions Solns (NASDAQ:ADES) is likely to report earnings for its second quarter.

    • Flexible Solutions Intl (AMEX:FSI) is estimated to report quarterly earnings at $0.07 per share on revenue of $9.55 million.

    • Fabrinet (NYSE:FN) is projected to report quarterly earnings at $1.54 per share on revenue of $581.50 million.

    • KULR Tech Gr (AMEX:KULR) is estimated to report quarterly loss at $0.03 per share on revenue of $880 thousand.

    • Gold Royalty (AMEX:GROY) is projected to report earnings for its third quarter.

    • AMMO (NASDAQ:POWW) is expected to report earnings for its first quarter.

    • Ideal Power (NASDAQ:IPWR) is estimated to report quarterly loss at $0.29 per share on revenue of $200 thousand.

    • Iridex (NASDAQ:IRIX) is projected to report quarterly loss at $0.15 per share on revenue of $13.92 million.

    • Duos Technologies Group (NASDAQ:DUOT) is projected to report quarterly loss at $0.26 per share on revenue of $2.70 million.

    • Nerdy (NYSE:NRDY) is likely to report earnings for its second quarter.

    • T2 Biosystems (NASDAQ:TTOO) is projected to report earnings for its second quarter.

    • GoHealth (NASDAQ:GOCO) is expected to report quarterly loss at $0.21 per share on revenue of $130.21 million.

    • Accelerate Diagnostics (NASDAQ:AXDX) is projected to report quarterly loss at $0.28 per share on revenue of $3.00 million.

    • CuriosityStream (NASDAQ:CURI) is expected to report quarterly loss at $0.28 per share on revenue of $20.99 million.

    • ThredUp (NASDAQ:TDUP) is projected to report earnings for its second quarter.

    • aTyr Pharma (NASDAQ:LIFE) is likely to report quarterly loss at $0.38 per share on revenue of $2.00 million.

    • Lucira Health (NASDAQ:LHDX) is likely to report quarterly loss at $0.34 per share on revenue of $30.05 million.

    • GreenBox POS (NASDAQ:GBOX) is likely to report quarterly loss at $0.20 per share on revenue of $5.66 million.

    • ENDRA Life Sciences (NASDAQ:NDRA) is likely to report earnings for its second quarter.

    • Peraso (NASDAQ:PRSO) is likely to report earnings for its second quarter.

    • Transphorm (NASDAQ:TGAN) is likely to report earnings for its first quarter.

    • Shoals Technologies Gr (NASDAQ:SHLS) is expected to report earnings for its second quarter.

    • Bird Glb (NYSE:BRDS) is estimated to report quarterly loss at $0.13 per share on revenue of $80.96 million.

    • Miromatrix Medical (NASDAQ:MIRO) is likely to report earnings for its second quarter.

    • Pioneer Power Solutions (NASDAQ:PPSI) is projected to report earnings for its second quarter.

    • WidePoint (AMEX:WYY) is expected to report earnings for its second quarter.

    • CYREN (NASDAQ:CYRN) is estimated to report earnings for its second quarter.

    • Remark Hldgs (NASDAQ:MARK) is projected to report earnings for its second quarter.

    • Quest Resource Holding (NASDAQ:QRHC) is projected to report earnings for its second quarter.

    • Vislink Technologies (NASDAQ:VISL) is projected to report earnings for its second quarter.

    • IZEA Worldwide (NASDAQ:IZEA) is estimated to report quarterly loss at $0.02 per share on revenue of $9.75 million.

    • Agora (NASDAQ:API) is estimated to report quarterly loss at $0.20 per share on revenue of $40.08 million.

    • Albireo Pharma (NASDAQ:ALBO) is estimated to report quarterly loss at $1.65 per share on revenue of $7.45 million.

    • CohBar (NASDAQ:CWBR) is likely to report earnings for its second quarter.

    • GAN (NASDAQ:GAN) is expected to report quarterly loss at $0.13 per share on revenue of $36.47 million.

    • Compass (NYSE:COMP) is expected to report quarterly loss at $0.14 per share on revenue of $2.12 billion.

    • Sema4 Holdings (NASDAQ:SMFR) is estimated to report earnings for its second quarter.

    • SomaLogic (NASDAQ:SLGC) is likely to report quarterly loss at $0.18 per share on revenue of $24.82 million.

    • Zenvia (NASDAQ:ZENV) is likely to report earnings for its second quarter.

    • IonQ (NYSE:IONQ) is likely to report quarterly loss at $0.10 per share on revenue of $2.39 million.

    • Urban-gro (NASDAQ:UGRO) is likely to report earnings for its second quarter.

    • SkyWater Technology (NASDAQ:SKYT) is estimated to report earnings for its second quarter.

    • Tencent Music Enter Gr (NYSE:TME) is projected to report quarterly earnings at $0.07 per share on revenue of $1.23 billion.

    • ZipRecruiter (NYSE:ZIP) is projected to report quarterly earnings at $0.06 per share on revenue of $234.81 million.

    • Intercorp Financial Servs (NYSE:IFS) is likely to report quarterly earnings at $0.76 per share on revenue of $295.00 million.

    • Vicinity Motor (NASDAQ:VEV) is expected to report earnings for its second quarter.

    • Yunhong CTI (NASDAQ:CTIB) is likely to report earnings for its second quarter.

    • Burcon NutraScience (NASDAQ:BRCN) is likely to report earnings for its first quarter.

    • Panbela Therapeutics (NASDAQ:PBLA) is likely to report earnings for its second quarter.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ABOS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABOS
    $ADES
    $ALBO
    $AMPS

    CompanyDatePrice TargetRatingAnalyst
    AEye Inc.
    $LIDR
    4/24/2026$3.50Buy
    Craig Hallum
    Li Auto Inc.
    $LI
    4/22/2026Underperform → Neutral
    BNP Paribas Exane
    IonQ Inc.
    $IONQ
    4/20/2026$55.00Outperform
    Northland Capital
    Fluence Energy Inc.
    $FLNC
    4/17/2026$8.00Neutral → Sell
    UBS
    Fabrinet
    $FN
    4/16/2026$700.00Overweight → Neutral
    Analyst
    Sanara MedTech Inc.
    $SMTI
    4/15/2026$32.00Buy
    Lake Street
    ThredUp Inc.
    $TDUP
    4/6/2026$5.00Buy
    TD Cowen
    AtaiBeckley Inc.
    $ATAI
    3/27/2026$12.00Buy
    Deutsche Bank
    More analyst ratings

    $ABOS
    $ADES
    $ALBO
    $AMPS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer O'Dowd William Iv bought $4,929 worth of shares (3,100 units at $1.59), increasing direct ownership by 0.69% to 450,090 units (SEC Form 4)

    4 - Dolphin Entertainment, Inc. (0001282224) (Issuer)

    3/16/26 7:33:14 PM ET
    $DLPN
    Other Consumer Services
    Consumer Discretionary

    Director Nakache Patricia bought $49,076 worth of shares (13,157 units at $3.73) (SEC Form 4)

    4 - ThredUp Inc. (0001484778) (Issuer)

    3/10/26 6:24:14 PM ET
    $TDUP
    Catalog/Specialty Distribution
    Consumer Discretionary

    Chief Executive Officer O'Dowd William Iv bought $4,843 worth of shares (2,900 units at $1.67), increasing direct ownership by 0.65% to 446,990 units (SEC Form 4)

    4 - Dolphin Entertainment, Inc. (0001282224) (Issuer)

    3/9/26 4:53:29 PM ET
    $DLPN
    Other Consumer Services
    Consumer Discretionary

    $ABOS
    $ADES
    $ALBO
    $AMPS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Craig Hallum initiated coverage on AEye with a new price target

    Craig Hallum initiated coverage of AEye with a rating of Buy and set a new price target of $3.50

    4/24/26 8:32:33 AM ET
    $LIDR
    Auto Parts:O.E.M.
    Consumer Discretionary

    Li Auto upgraded by BNP Paribas Exane

    BNP Paribas Exane upgraded Li Auto from Underperform to Neutral

    4/22/26 7:43:24 AM ET
    $LI
    Auto Manufacturing
    Industrials

    Northland Capital initiated coverage on IonQ with a new price target

    Northland Capital initiated coverage of IonQ with a rating of Outperform and set a new price target of $55.00

    4/20/26 8:26:58 AM ET
    $IONQ
    EDP Services
    Technology

    $ABOS
    $ADES
    $ALBO
    $AMPS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    April 17, 2023 - FDA Approves Cell Therapy for Patients with Blood Cancers to Reduce Risk of Infection Following Stem Cell Transplantation

    For Immediate Release: April 17, 2023 Today, the U.S. Food and Drug Administration approved Omisirge (omidubicel-onlv), a substantially modified allogeneic (donor) cord blood-based cell therapy to quicken the recovery of neutrophils (a subset of white blood cells) in the body and reduce the risk of infection. The product is intended for use in adults and pediatric patients 12 years and older with blood cancers p

    4/17/23 1:02:15 PM ET
    $GMDA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for BIJUVA issued to THERAPEUTICSMD INC

    Submission status for THERAPEUTICSMD INC's drug BIJUVA (SUPPL-6) with active ingredient ESTRADIOL; PROGESTERONE has changed to 'Approval' on 12/28/2021. Application Category: NDA, Application Number: 210132, Application Classification: Efficacy

    12/29/21 7:23:57 AM ET
    $TXMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for IMVEXXY issued to THERAPEUTICSMD INC

    Submission status for THERAPEUTICSMD INC's drug IMVEXXY (SUPPL-2) with active ingredient ESTRADIOL has changed to 'Approval' on 11/16/2021. Application Category: NDA, Application Number: 208564, Application Classification: Labeling

    11/17/21 4:38:32 AM ET
    $TXMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABOS
    $ADES
    $ALBO
    $AMPS
    SEC Filings

    View All

    Immersion Corporation filed SEC Form 8-K: Other Events

    8-K - IMMERSION CORP (0001058811) (Filer)

    4/24/26 8:30:31 AM ET
    $IMMR
    Computer peripheral equipment
    Technology

    SEC Form DEFM14A filed by Stratus Properties Inc.

    DEFM14A - STRATUS PROPERTIES INC (0000885508) (Filer)

    4/24/26 6:01:54 AM ET
    $STRS
    Homebuilding
    Real Estate

    Tivic Health Systems Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - Tivic Health Systems, Inc. (0001787740) (Filer)

    4/23/26 4:36:54 PM ET
    $TIVC
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $ABOS
    $ADES
    $ALBO
    $AMPS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Chief Risk & Compl. Officer Hilberg Christopher covered exercise/tax liability with 1,083 shares, decreasing direct ownership by 3% to 39,656 units (SEC Form 4) (withholding obligation)

    4/A - SkyWater Technology, Inc (0001819974) (Issuer)

    4/23/26 5:22:49 PM ET
    $SKYT
    Semiconductors
    Technology

    SEC Form 4 filed by Venker Eric

    4 - Roivant Sciences Ltd. (0001635088) (Issuer)

    4/22/26 6:27:47 PM ET
    $ROIV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Pulik Richard

    4 - Roivant Sciences Ltd. (0001635088) (Issuer)

    4/22/26 6:26:48 PM ET
    $ROIV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABOS
    $ADES
    $ALBO
    $AMPS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Tivic Health Systems Rebrands as Valion Bio, Reflecting Completed Transformation into a Late-Stage Biopharmaceutical Company with Government-Backed Asset and Potential Multiple Revenue Stream Model

    Ticker Symbol to Change from TIVC to VBIO Effective April 28, 2026; Company Advancing Entolimod™ Toward BARDA Funding and Strategic National Stockpile Procurement While Velocity Bioworks CDMO Builds Independent Revenue BaseSAN ANTONIO, April 23, 2026 /PRNewswire/ -- Tivic Health Systems, Inc. (NASDAQ:TIVC) today announced it is changing its corporate name to Valion Bio, Inc. and its Nasdaq ticker symbol from TIVC to VBIO, effective at market open on Tuesday, April 28, 2026. The CUSIP number for the company's common stock will remain unchanged. The rebrand is not merely cosmetic.

    4/23/26 4:05:00 PM ET
    $TIVC
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Quest Resource Holding Corporation to Report First Quarter 2026 Financial Results and Host Earnings Call on May 7, 2026

    IRVING, Texas, April 23, 2026 (GLOBE NEWSWIRE) -- Quest Resource Holding Corporation (NASDAQ:QRHC) ("Quest" or the "Company"), a national leader in environmental waste and recycling services, today announced that it will release results for its first quarter ended March 31, 2026, on Thursday, May 7, 2026, after market close. Management will host a conference call that same day at 5:00 PM ET to review the Company's financial results and business outlook. Investors interested in participating in the live call can dial 1-877-270-2148 or 1-412-317-6060 (International). Investors can also access the call online through a listen-only webcast on the investor relations section of Quest's website

    4/23/26 4:05:00 PM ET
    $QRHC
    Environmental Services
    Utilities

    Blend to Announce First Quarter 2026 Financial Results on May 7, 2026

    Blend Labs, Inc. (NYSE:BLND), a leading digital origination platform, today announced that the Company's first quarter 2026 financial results will be released after market close on Thursday, May 7, 2026. The Company will host a conference call to discuss its results at 1:30 p.m. PT / 4:30 p.m. ET the same day. A link to the live call can be accessed at the Company's Investor Relations website at investor.blend.com, along with the Company's earnings press release, financial information, and slide presentation. Following the call, a replay will be available at the same website. About Blend Blend Labs, Inc. (NYSE:BLND) is a leading origination platform for digital banking solutions. Fina

    4/23/26 4:00:00 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    $ABOS
    $ADES
    $ALBO
    $AMPS
    Leadership Updates

    Live Leadership Updates

    View All

    urban-gro, Inc. (Nasdaq: UGRO) — Sri Lanka Cricket Confirms July 10 – August 5, 2026 and Four Venues for Lanka Premier League Season 6; Tournament Conducted in Partnership with UGRO Subsidiary IPG Group

    LAFAYETTE, Colo., April 23, 2026 (GLOBE NEWSWIRE) -- urban-gro, Inc. (NASDAQ:UGRO) ("urban-gro" or the "Company"), operating through Flash Sports & Media, Inc., today noted the official announcement by Sri Lanka Cricket ("SLC") confirming the dates, venues, and player-registration timeline for Lanka Premier League ("LPL") Season 6. The tournament will run from July 10 to August 5, 2026, and is owned by SLC and conducted in partnership with Innovative Production Group FZ, LLC ("IPG"), the event rights holder. The Company participates in the tournament through its subsidiary, IPG under existing commercial arrangements. Season 6 — By the Numbers Tournament windowJuly 10 – August 5, 2026 (

    4/23/26 7:05:00 AM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary

    IonQ Achieves Key Photonic Interconnect Milestone, Demonstrating Networked Quantum Systems Using Entanglement

    As part of a joint project with Air Force Research Laboratory, IonQ constructs first networked quantum systems among remote quantum processing units. [Case Number: AFRL-2026-1742] IonQ (NYSE:IONQ), the leading quantum company, today announced it has achieved a foundational technical milestone by photonically interconnecting two independent trapped-ion quantum systems. This achievement marks the first demonstration of connected, commercial quantum computers, a critical step toward scaling quantum computation beyond a single processor. By successfully linking two remote quantum systems, IonQ has validated the generation, transmission, and detection of photons used to enable quantum entang

    4/14/26 9:25:00 AM ET
    $IONQ
    EDP Services
    Technology

    Navitas Semiconductor Appoints Gregory M. Fischer as Independent Director to its Board

      Ex-Broadcom Executive Brings Over 40 Years of Semiconductor Technology and Business Leadership Experience to Navitas' Board as Part of Strategic Transformation to High-Power Markets TORRANCE, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Navitas Semiconductor, (NASDAQ:NVTS), an industry leader in next-generation GaNFast™ gallium nitride (GaN) and GeneSiC™ silicon carbide (SiC) power semiconductors, today announced the appointment of semiconductor veteran, Gregory M. Fischer, to its Board effective immediately. Fischer brings extensive semiconductor operating experience to the Board and will stand for reelection in 2027 as a Class III director. He will serve on the Compensation and Executi

    4/13/26 4:05:00 PM ET
    $NVTS
    Semiconductors
    Technology

    $ABOS
    $ADES
    $ALBO
    $AMPS
    Financials

    Live finance-specific insights

    View All

    Quest Resource Holding Corporation to Report First Quarter 2026 Financial Results and Host Earnings Call on May 7, 2026

    IRVING, Texas, April 23, 2026 (GLOBE NEWSWIRE) -- Quest Resource Holding Corporation (NASDAQ:QRHC) ("Quest" or the "Company"), a national leader in environmental waste and recycling services, today announced that it will release results for its first quarter ended March 31, 2026, on Thursday, May 7, 2026, after market close. Management will host a conference call that same day at 5:00 PM ET to review the Company's financial results and business outlook. Investors interested in participating in the live call can dial 1-877-270-2148 or 1-412-317-6060 (International). Investors can also access the call online through a listen-only webcast on the investor relations section of Quest's website

    4/23/26 4:05:00 PM ET
    $QRHC
    Environmental Services
    Utilities

    Blend to Announce First Quarter 2026 Financial Results on May 7, 2026

    Blend Labs, Inc. (NYSE:BLND), a leading digital origination platform, today announced that the Company's first quarter 2026 financial results will be released after market close on Thursday, May 7, 2026. The Company will host a conference call to discuss its results at 1:30 p.m. PT / 4:30 p.m. ET the same day. A link to the live call can be accessed at the Company's Investor Relations website at investor.blend.com, along with the Company's earnings press release, financial information, and slide presentation. Following the call, a replay will be available at the same website. About Blend Blend Labs, Inc. (NYSE:BLND) is a leading origination platform for digital banking solutions. Fina

    4/23/26 4:00:00 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    Amtech Systems to Announce Fiscal 2026 Second Quarter Financial Results on May 7, 2026

    Amtech Systems, Inc. ("Amtech") (NASDAQ:ASYS), a manufacturer of equipment and consumables enabling AI semiconductor device packaging and advanced substrate fabrication, will announce financial results for its fiscal 2026 second quarter ended March 31, 2026 on May 7, 2026 after market close. Amtech Systems will host a conference call at 5:00 pm ET on May 7, 2026 to discuss fiscal 2026 second quarter financial results. The call will be available to interested parties by dialing 1-412-317-6060. A live webcast of the conference call will be available in the Investor Relations section of Amtech's website at: https://www.amtechsystems.com/investors/events. A replay of the webcast will be avail

    4/23/26 9:00:00 AM ET
    $ASYS
    Industrial Machinery/Components
    Technology

    $ABOS
    $ADES
    $ALBO
    $AMPS
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at urban-gro Inc. on Jun 6

    Urban-gro Inc. saw an interesting insider purchase on June 6, 2024, when Wilks Lewis bought $29,000 worth of shares, acquiring 20,000 units at a price of $1.45 per unit. This transaction increased Lewis' direct ownership by 12% to 184,108 units, as reported in SEC Form 4. Insider transactions like this can provide valuable insights for investors, indicating confidence in the company's future prospects. Analyzing the insider activity surrounding Urban-gro Inc., we can observe several transactions that may reveal patterns or insights. Looking back at previous filings, on September 1, 2023, Wilks Lewis purchased $10,300 worth of shares, acquiring 10,000 units at $1.03 per unit. This

    6/10/24 12:49:49 AM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary

    $ABOS
    $ADES
    $ALBO
    $AMPS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Quipt Home Medical Corp.

    SC 13D - Quipt Home Medical Corp. (0001540013) (Subject)

    12/11/24 4:07:36 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by Quipt Home Medical Corp.

    SC 13G/A - Quipt Home Medical Corp. (0001540013) (Subject)

    12/11/24 4:06:42 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13G filed by Quipt Home Medical Corp.

    SC 13G - Quipt Home Medical Corp. (0001540013) (Subject)

    12/11/24 4:06:09 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care